Authors

David Mulder

Counsel

Read More

Christian Dekoninck

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Dr Paul England

Senior Counsel – Knowledge

Read More
Authors

David Mulder

Counsel

Read More

Christian Dekoninck

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Dr Paul England

Senior Counsel – Knowledge

Read More

9 November 2020

Pharmaceutical patent law – 1 of 2 Insights

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

  • Quick read

What is the role of patent law in emergency situations like the current coronavirus pandemic? And what exceptions to the law are there under such circumstances?

In the first article of our two-part series written for the European Intellectual Property Review, our international team consider these questions and more on both a broad, European level and from the perspective of six national jurisdictions.

Read the article here

In this series

Patents & innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

9 November 2020

by Multiple authors

Patents & innovation

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

23 November 2020

by Multiple authors

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Life sciences & healthcare

Early IP Strategy for Life Sciences Start-Ups Pays off

We explain the 5 biggest pitfalls

22 March 2024
Briefing

by Dr. Anja Lunze, LL.M. and Tobias Baus, LL.M., Dipl.-Ing.

Click here to find out more
UPC

The first 100 days of the UPC from a life sciences perspective – a very good message

20 September 2023
Quick read

by Dr. Anja Lunze, LL.M. and Dr. Nora E. Wessendorf, LL.M. (Washington)

Click here to find out more
Life sciences & healthcare

Personalised medicines and exclusive protection

19 July 2023

by Dr Paul England

Click here to find out more